HomeInsightsMarket Capitalization

Market Capitalization of Beta Drugs Ltd

Market Capitalization of Beta Drugs Ltd

stocks purchased

₹ 0.5 Cr

Volume Transacted

()

stocks purchased

2.2 K

Stocks Traded

()

Last Updated on: Nov 08, 2024

Image

Beta Drugs Ltd

NSE: BETA

MARKETCAP

₹ 2076.72 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Beta Drugs Ltd is ₹ 2076 crore as of 07 Nov 24.
  • The Market Cap of Beta Drugs Ltd changed from ₹ 90.56 crore on March 2019 to ₹ 1186 crore on March 2024 . This represents a CAGR of 53.53% over 6 years. .
  • The Latest Trading Price of Beta Drugs Ltd is ₹ 2145 as of 08 Nov 09:34.

Historical Market Cap of Beta Drugs Ltd

No data available

* All values are in crore

Company Fundamentals for Beta Drugs Ltd

No data available

Image

Beta Drugs Ltd

NSE: BETA

PRICE

₹ 2145.1

-15.05 (-0.70%)

stock direction

Last updated on: Nov 08 09:34 AM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20242160.15
06 Nov 20241984.5
05 Nov 20241944.15
04 Nov 20241981.25
01 Nov 20241971.3
31 Oct 20241916.55
30 Oct 20241908.85
29 Oct 20241942.6
28 Oct 20241801.9
25 Oct 20241682.35

SWOT Analysis Of Beta Drugs Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Beta Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Beta Drugs Ltd

No data available

No data available

Historical P/E Ratio of Beta Drugs Ltd

No data available

* All values are in %

Historical Revenue of Beta Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Beta Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beta Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

Beta Drugs Ltd News Hub

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024...

Read more

04 Nov 202414:01

News

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Oct 202413:59

News

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be hel...

Read more

02 Sep 202417:17

News

Beta Drugs to discuss results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 14 May 2024 Pow...

Read more

07 May 202412:58

News

Beta Drugs to table results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 7 November 2023...

Read more

01 Nov 202316:05

News

Beta Drugs AGM scheduled

Beta Drugs announced that the 18th Annual General Meeting (AGM) of the company will be hel...

Read more

05 Sep 202315:24

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Beta Drugs Ltd Market Cap

What is the market cap of Beta Drugs Ltd?

As of November 8, 2024, Beta Drugs Ltd has a market capitalization of ₹2076.72, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Beta Drugs Ltd's market capitalization?

Beta Drugs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Beta Drugs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Beta Drugs Ltd's market capitalization change?

Beta Drugs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*